Age-related macular degeneration: Strategies for cellular therapyTuesday, 23 April 2013 at 11:30 Add to Calendar ▼2013-04-23 11:30:002013-04-23 12:30:00Europe/LondonAge-related macular degeneration: Strategies for cellular therapyClinical Translation of Stem Cells Summit in Palm Springs, CA, USAPalm Springs, CA, USASELECTBIOenquiries@selectbiosciences.com Eye diseases impact society in devastating fashion, and, although there is a wealth of knowledge about ocular biology, treatment strategies are still lacking. There is great promise in emerging cellular therapies for ocular disease, and efforts are under way to replace retinal pigmented epithelium (RPE) to treat age-related macular degeneration (AMD) and other blinding disorders. The eye has many advantages for the development of cellular therapies, and RPE cells have been derived from both human embryonic stem cells (hESC) and induced pluripotent stem cells (iPSC). Significant advances have been made in methods for differentiation and expansion of stem cell derived RPE, and several strategies are being pursued for transplantation and monitoring of cells. |